Skip to content

Comparative study of oral and intravenous hydration for prevention of contrast-induced acute kidney injury after CT enhancement in patients with stage third chronic kidney disease

Comparative study of oral and intravenous hydration for prevention of contrast-induced acute kidney injury after CT enhancement in patients with stage third chronic kidney disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073802
Enrollment
Unknown
Registered
2023-07-21
Start date
2023-07-23
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast-induced acute kidney injury

Interventions

Group A/Oral hydration group/experimental group:Drink 500 mL of water within two hours before CT enhancement and 2000 mL of water within 24 hours after CT enhancement
Group B/Control group:0.9% NaCl was injected intravenously 3-4 mL/kg/h, 4 hours before and 4 hours after administration of the contrast agent

Sponsors

the First Affiliated Hospital of Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Hospitalized patients (2) Age 18 or above (3) Informed consent and strict adherence to the research protocol (4) The range of eGFR that meets the definition of CKD3 stage is 30-60mL/min/1.73m2 (excluding 60mL/min/1.73m2), and eGFR is calculated using the CKD-EPI formula

Exclusion criteria

Exclusion criteria: (1) Allergic to iodine contrast agents; (2) pregnant or lactating persons; (3) Patients with hyperthyroid or asthma; (4) pancreatitis, intestinal obstruction, gastrointestinal dysfunction, etc. before and after the examination can not drink water; (5) Patients who cannot stop metformin 2 days before and after the examination due to the need of disease; (6) accompanied by serious systemic diseases, such as severe heart failure (LVEF < 35% or NYHA grade IV), acute heart failure, kidney failure, etc.; (7) Patients who have taken any nephrotoxic drugs such as aminoglycoside, vancomycin, cephalosporin or aspirin within 48 hours or several hours before the examination; (8) Serum creatinine value (sCr) was measured in the week before intravenous administration of iodine contrast agent.

Design outcomes

Primary

MeasureTime frame
Incidence of CI-AKI 48 to 72 hours after administration of contrast agent;

Secondary

MeasureTime frame
The mean relative increase in serum creatinine levels from baseline 2 to 3 days after administration of the contrast agent;adverse event;

Countries

China

Contacts

Public ContactLuo Chunliu

the First Affiliated Hospital of Jinan University

jnuchll@163.com+86 189 2620 2718

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026